Search Results
Results found for "Ross W Cheloha"
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
droplets; novel atypical GPCR-arrestin complexes; Lilly's oral GLP-1, orforglipron, delivers weight loss
- 📰 GPCR Weekly News, February 20 to 26, 2023
Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite Loss
- The One Reason Why Biotech Startups Fail More Often Than They Should
The illusion of progress and the slow loss of direction One of the most dangerous phases in a biotech
- GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures
EC₅₀ and Emax uncouple affinity and efficacy, making cross-agonist comparison unreliable. Dr.
- Chemokine receptor-targeted drug discovery: progress and challenges
Further difficulties arise from the existence of cross-reactivity with other GPCRs and differences in
- 📰 GPCR Weekly News, January 29 to February 4, 2024
Structural and functional insight into the interaction of Clostridioides difficile toxin B and FZD7 Loss-of-function
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
from November 25th to December 1st, 2024 Industry News Amgen says obesity drug caused up to 20% weight loss
- 📰 GPCR Weekly News
Unusual phototransduction via cross-motif signaling from Gq to adenylyl cyclase in intrinsically photosensitive
